Steve Riendeau

Steve Riendeau serves as Chief Commercial Officer at Sinocare Inc., overseeing PTS Diagnostics and Trividia Health since February 2022. Previously, Riendeau held the role of VP Global Sales at PTS Diagnostics, where responsibilities included designing and leading the international commercial strategy for the CardioChek system and rebuilding the commercial organization following an FDA warning. Prior to that, Riendeau was Executive Director of Eastern U.S. operations at Specialty Laboratories/Ameripath, focusing on turnaround strategies after a CMS citation. Early career experience includes a Sales Manager position at Myriad Genetics, where Riendeau contributed to the commercialization strategy for BRCA1 and BRCA2 genetic testing. Educational background includes a Bachelor of Science in Economics from Florida State University.